Related Experiment Video
Updated: May 13, 2026

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Weight status of children with sickle cell disease
Anjulika Chawla1, Philippa G Sprinz, Jennifer Welch
1Division of Pediatric Hematology/Oncology, Warren Alpert Medical School of Brown University/Hasbro Children's Hospital, 593 Eddy St, Providence, RI 02903, USA. achawla@lifespan.org
Insights
Nearly a quarter of children with sickle cell disease (SCD) are overweight or obese. Higher hemoglobin levels correlate with increased weight status in pediatric SCD patients, warranting further research.
Area of Science:
- Pediatric Hematology
- Public Health
- Genetics
Background:
- Historically, children and adolescents with sickle cell disease (SCD) often presented as underweight.
- Advances in SCD treatment, such as hydroxyurea, have shown potential for improving growth trajectories.
- This study investigates the relationship between hemoglobin levels and weight status in pediatric SCD patients.
Purpose of the Study:
- To test the hypothesis that higher hemoglobin (Hb) levels are associated with increased weight status in children and adolescents with SCD.
- To determine the prevalence of underweight, overweight, and obesity in a pediatric SCD population in New England.
Main Methods:
- A retrospective chart review was conducted on 675 patients aged 2-19 years across 6 institutions in New England between 2007-2009.
- Data collected included height, weight, baseline Hb levels, demographics, and comorbidities.
- Body Mass Index (BMI) percentiles were used to define underweight (<5th percentile) and overweight/obesity (≥85th/≥95th percentile).
Main Results:
- In the study sample, 22.4% of children and adolescents with SCD were overweight or obese, while 6.7% were underweight.
- Overweight/obesity was associated with non-Hb SS or Hb Sβ(0) genotypes and higher baseline Hb levels.
- Each 1 g/dL increase in baseline Hb levels was associated with a 36% increased odds of being overweight/obese, after adjusting for covariates.
Conclusions:
- A significant proportion (nearly one-quarter) of children and adolescents with SCD in New England are overweight or obese.
- Underweight status was linked to male gender, older age, and SCD-related complications.
- Further longitudinal studies are essential to understand the long-term effects of elevated BMI on morbidity and mortality in individuals with SCD.
Objective:
Historically, many children and adolescents with sickle cell disease (SCD) were underweight. Treatment advances like hydroxyurea have been associated with improved growth. We hypothesized that increased hemoglobin (Hb) levels would be associated with increased weight status of children with SCD.
Methods:
Investigators at 6 institutions conducted a retrospective chart review of all patients aged 2 to 19 years of age for the calendar years 2007-2009. Height, weight, baseline Hb levels, demographic information, and select comorbidities were recorded from the most recent clinic visit. Overweight and obesity were defined as ≥85th and ≥95th BMI percentiles for age and gender, respectively, and underweight was defined as <5th BMI percentile.
Results:
Data were collected on 675 children and adolescents in 3 New England states. In this sample, 22.4% were overweight or obese, whereas only 6.7% were underweight. Overweight or obese status was associated with sickle genotypes other than Hb SS or Hb Sβ(0) disease, and were associated with higher baseline Hb levels. Underweight individuals were more likely to be male, older, and have had at least 1 SCD-related complication. After adjusting for demographic factors, any SCD-related complication, SCD-directed treatments, and obesity-related conditions, there was a 36% increased odds of overweight/obesity for each 1 g/dL increase in baseline Hb levels.
Conclusions:
Nearly one-quarter of children and adolescents with SCD in New England are overweight or obese. Longitudinal studies are needed to determine the impact of elevated BMI on the morbidity and mortality of both children and adults with SCD.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Multiple Allele Traits
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Drug Dosing: Obese Patients
Chronic Kidney Disease II: Clinical Manifestations
